Table 4.
Studies | Number and percentage of patients who have improved (slightly, much and very much) at the end of the study |
Number and percentage of participants who experienced any adverse events |
||
---|---|---|---|---|
Treatment | Control | Treatment | Control | |
Backonja et al., 2008 | 114 (55%) | 85 (43%), | 203 (99%) | 174 (88%) |
Webster et al., 2010a | 122 (55%) | 32 (41%) | 131 (59%) | 43 (56%) |
Webster et al., 2010b | 41 (43%) | 15 (30%) | 76 (75%) | 28 (53%) |
Irving et al., 2011 | 123 (61%) | 91 (47%) | 208 (98%) | 177 (87%) |
Watson et al., 1993 | 91 (64%) | 17 (25%) | 45 (61%) | 23 (33%) |
Bernstein et al., 1989 | 4 (46%) | 1 (6%) | NA | NA |